Monika Gawalko

Monika Gawalko

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Assoc. Prof. Monika Gawałko, MD, PhD, is PostDoctoral Researcher at the University of Adelaide and cardiology/ EP fellow at the Medical University of Warsaw. She is an active member of the ESC Social Media Editorial team and serves as a Nucleus Member and Communication Coordinator of the ESC Working Group on e-Cardiology. Her training includes fellowships in Maastricht (the Netherlands), Copenhagen (Denmark), Essen (Germany). Her research is centered on arrhytmias, mainly on atrial fibrillation, and related areas, including heart rhythm and rate control treatments, mobile health solutions, lifestyle risk factors such as obesity and nutrition, anticoagulation, and the underlying mechanisms, such as the paracrine effects of pericardial adipose tissue, the NLRP3 inflammasome, and the gut microbiome.

  • Appointments
    Date Position Institution name
    2024 - ongoing PostDoctoral Researcher University of Adelaide
    2022 - ongoing Cardiologist in training Medical University of Warsaw
    2021 - ongoing PostDoctoral Researcher Medical University of Warsaw
    2021 - 2023 PostDoctoral Researcher Maastricht University Medical Centre

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2025 Scholarship Bekker programme scholar Polish National Agency for Academic Exchange Poland -
    2025 Scholarship MINIATURA programme scholar National Science Centre Poland -
    2024 Distinction Gold Scalpel distinction Pulse of medicine Poland -
    2024 Award Rector's prize, second-/third-degree individual award Medical University of Warsaw Poland -
    2023 Award Gold Otis; Scientific debuts Gold Otis Trust Award Institute Poland -
    2023 Scholarship START programme scholar Foundation for Polish Science Poland -
    2023 Scholarship Scholarship for young scientists Medical University of Warsaw Poland -
    2023 Award Rector's prize, First-/second-/third-degree individual award Medical University of Warsaw Poland -
    2022 Award The L'Oréal-UNESCO For Women in Science Award L'Oréal-UNESCO Poland -
    2022 Achievement List of the 100 most influential women by Forbes Poland Forbes Poland Poland -
    2022 Award Wissenschaftspreis Publikation, the best publication Deutschen Gesellschaft für digitale Medizin Germany -
    2021 Scholarship Specialized Research Fellowship Club 30 Polish Society of Cardiology Poland -
    2021 Scholarship First Contact Initiative Grant from Council on Basic Cardiovascular Science European Society of Cardiology France -
    2021 Award Polish Minister of Science and Higher Education scholarship for Outstanding Young Scientists Ministry of Science and Higher Education Poland -
    2020 Scholarship PROM programme scholar Polish National Agency for Academic Exchange Poland -
    2020 Scholarship ERASMUS+ programme scholar Medical University of Warsaw Poland -
    2018 Award Rector’s Prize, First-degree individual award Medical University of Warsaw Poland -
    2018 Award Medical Laurels Doctor Wacław Mayzl Polish Academy of Sciences Poland -
    2018 Award Golden Badge, Student Scientific Society Medical University of Warsaw Poland -

  • Education
    Date Institution name Country Title
    Medical University of Warsaw Poland MD
    Medical University of Warsaw Poland PhD
    Medical University of Warsaw Poland Associate Professor

  • Journals
    Year Citation
    2025 Sandgren, E., Betz, K., Gawalko, M., Hermans, A., Habibi, Z., Verhaert, D., . . . Linz, D. (2025). Feasibility of repeated on-demand smartphone app–based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: Data from the ISOLATION study. Heart Rhythm, S1547-5271(25)00386-8.
    DOI
    2024 Gawałko, M., Middeldorp, M. E., Saljic, A., Penders, J., Jespersen, T., Albert, C. M., . . . Linz, D. (2024). Diet and risk of atrial fibrillation: a systematic review. European Heart Journal, 45(40), 4259-4274.
    DOI Scopus1
    2024 Sandgren, E., Hermans, A. N. L., Gawalko, M., Betz, K., Sohaib, A., Fung, C. H., . . . Linz, D. (2024). Smartphone app-based approximation of time spent with atrial fibrillation and symptoms in patients after catheter ablation: data from the TeleCheck-AF project. Europace, 26(10), 11 pages.
    DOI Scopus1 Europe PMC1
    2024 Pieszko, K., Hiczkiewicz, J., Łojewska, K., Uziȩbło-Zyczkowska, B., Krzesiński, P., Gawałko, M., . . . Slomka, P. J. (2024). Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry. European Heart Journal, 45(1), 32-41.
    DOI Scopus16 Europe PMC2
    2024 Gawałko, M., Betz, K., Hendriks, V., Hermans, A. N. L., van der Velden, R. M. J., Manninger, M., . . . Linz, D. (2024). Changes in healthcare utilisation during implementation of remote atrial fibrillation management: TeleCheck-AF project. Netherlands Heart Journal, 32(3), 130-139.
    DOI Scopus4 WoS1 Europe PMC4
    2024 Linz, D., Gawalko, M., Betz, K., Hendriks, J. M., Lip, G. Y. H., Vinter, N., . . . Johnsen, S. (2024). Atrial fibrillation: epidemiology, screening and digital health. The Lancet Regional Health - Europe, 37, 20 pages.
    DOI Scopus79 Europe PMC57
    2024 Kaufmann, D., Królak, T., Dąbrowska-Kugacka, A., Kapłon-Cieślicka, A., Gawałko, M., Budnik, M., . . . Daniłowicz-Szymanowicz, L. (2024). Can transesophageal echocardiography be safely omitted in patients scheduled for elective ablation of atrial arrhythmias? Data based on the LATTEE registry. Kardiologia Polska, 82(5), 492-499.
    DOI Scopus2
    2024 Maciorowska, M., Uzieblo-Zyczkowska, B., Gorczyca-Glowacka, I., Wozakowska-Kaplon, B., Jelonek, O., Wojcik, M., . . . Krzesinsk, P. (2024). Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF). KARDIOLOGIA POLSKA, 82(1), 37-45.
    DOI
    2024 Uziębło-Życzkowska, B., Gorczyca-Głowacka, I., Wożakowska-Kapłon, B., Jelonek, O., Wójcik, M., Błaszczyk, R., . . . Maciorowska, M. (2024). Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF). Kardiologia Polska, 82(1), 37-45.
    DOI Scopus4 Europe PMC1
    2023 Gawałko, M., Budnik, M., Uziębło-Życzkowska, B., Gorczyca, I., Krzesiński, P., Scisło, P., . . . Kapłon-Cieślicka, A. (2023). Risk of left atrial appendage thrombus in older patients with atrial fibrillation. Archives of Medical Science, 19(6), 1721-1730.
    DOI Scopus3 Europe PMC2
    2023 Hermans, A. N. L., Isaksen, J. L., Gawalko, M., Pluymaekers, N. A. H. A., van der Velden, R. M. J., Snippe, H., . . . Linz, D. (2023). Accuracy of continuous photoplethysmography-based 1 min mean heart rate assessment during atrial fibrillation. Europace, 25(3), 835-844.
    DOI Scopus11 Europe PMC8
    2023 Betz, K., Verhaert, D. V. M., Gawalko, M., Hermans, A. N. L., Habibi, Z., Pluymaekers, N. A. H. A., . . . Linz, D. (2023). Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: insights from the Virtual-SAFARI study. Clinical Research in Cardiology, 112(6), 834-845.
    DOI Scopus4 WoS2 Europe PMC2
    2023 Van Der Velden, R. M. J., Hereijgers, M. J. M., Arman, N., Van Middendorp, N., Franssen, F. M. E., Gawalko, M., . . . Linz, D. (2023). Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation. Europace, 25(7), 1-10.
    DOI Scopus9 WoS2 Europe PMC7
    2023 Gawałko, M., Hermans, A. N. L., Van Der Velden, R. M. J., Betz, K., Vm Verhaert, D., Hillmann, H. A. K., . . . Hendriks, J. M. (2023). Patient motivation and adherence to an on-demand app-based heart rate and rhythm monitoring for atrial fibrillation management: data from the TeleCheck-AF project. European Journal of Cardiovascular Nursing, 22(4), 412-424.
    DOI Scopus17 WoS7 Europe PMC17
    2023 Gawałko, M., Saljic, A., Li, N., Abu-Taha, I., Jespersen, T., Linz, D., . . . Dobrev, D. (2023). Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovascular Research, 119(3), 614-630.
    DOI Scopus35 WoS14 Europe PMC26
    2023 Milewski, K., Balsam, P., Kachel, M., Sitek, B., Kolarczyk-Haczyk, A., Skoczyński, S., . . . Grabowski, M. (2023). Actual status and future directions of cardiac telerehabilitation. Cardiology Journal, 30(1), 12-23.
    DOI Scopus3 Europe PMC2
    2023 Gawałko, M., & Linz, D. (2023). Atrial Fibrillation Detection and Management in Hypertension. Hypertension, 80(3), 523-533.
    DOI Scopus20 WoS4 Europe PMC14
    2023 Gawałko, M., Linz, D., & Dobrev, D. (2023). Does weight matter in cryoballoon ablation?. IJC Heart and Vasculature, 47, 101251.
    DOI Scopus1 Europe PMC1
    2023 Budnik, M., Gawałko, M., Lodziński, P., Tymińska, A., Ozierański, K., Grabowski, M., . . . Balsam, P. (2023). Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry. ESC Heart Failure, 10(1), 637-649.
    DOI Scopus4 Europe PMC3
    2022 Ciba-Stemplewska, A., Gorczyca-Głowacka, I., Kapłon-Cieślicka, A., Uziębło-Życzkowska, B., Budnik, M., Gawałko, M., . . . Wożakowska-Kapłon, B. (2022). Differences in the predictors of left atrial appendage thrombus between men and women treated with dabigatran or rivaroxaban. Polish Archives of Internal Medicine, 132(9), 9 pages.
    DOI
    2022 Uziȩbło-Życzkowska, B., Kapłon-Cieślicka, A., Gawałko, M., Budnik, M., Starzyk, K., Wożakowska-Kapłon, B., . . . Krzesiński, P. (2022). Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry. Frontiers in Cardiovascular Medicine, 9, 9 pages.
    DOI Scopus3 Europe PMC3
    2022 Szyszkowska, A., Kuźma, Ł., Wożakowska-Kapłon, B., Gorczyca-Głowacka, I., Jelonek, O., Uziębło-Życzkowska, B., . . . Tomaszuk-Kazberuk, A. (2022). Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry. International Journal of Environmental Research and Public Health, 19(19), 13 pages.
    DOI
    2022 Uziębło-Życzkowska, B., Kapłon-Cieślicka, A., Kiliszek, M., Gawałko, M., Budnik, M., Starzyk, K., . . . Krzesiński, P. (2022). Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients—Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry. Nutrients, 14(17), 11 pages.
    DOI Scopus1 Europe PMC1
    2022 Wybraniec, M. T., Mizia-Szubryt, M., Cichoń, M., Wrona-Kolasa, K., Kapłon-Cieślicka, A., Gawałko, M., . . . Mizia-Stec, K. (2022). Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter. ESC Heart Failure, 9(6), 4064-4076.
    DOI Scopus7 Europe PMC5
    2022 Kaufmann, D., Wabich, E., Kapłon-Cieślicka, A., Gawałko, M., Budnik, M., Uziębło-Życzkowska, B., . . . Daniłowicz-Szymanowicz, L. (2022). Echocardiographic predictors of thrombus in left atrial appendage—The role of novel transthoracic parameters. Frontiers in Cardiovascular Medicine, 9, 10 pages.
    DOI Scopus5 Europe PMC1
    2022 van der Velden, R. M. J., Hermans, A. N. L., Pluymaekers, N. A. H. A., Gawalko, M., Elliott, A., Hendriks, J. M., . . . Simons, S. O. (2022). Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach.. International journal of cardiology. Heart & vasculature, 42, 1-7.
    DOI Scopus12 WoS1 Europe PMC8
    2022 Hermans, A. N. L., Gawalko, M., Slegers, D. P. J., Andelfinger, N., Pluymaekers, N. A. H. A., Verhaert, D. V. M., . . . Linz, D. (2022). Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation.. International journal of cardiology, 367, 29-37.
    DOI Scopus19 WoS5 Europe PMC18
    2022 Gawałko, M., & Sanders, P. (2022). Drug abuse and risk of atrial fibrillation: a neglected association.. Eur Heart J, 43(47), 4943-4945.
    DOI Scopus4 WoS3 Europe PMC1
    2022 Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Duncker, D., . . . Linz, D. (2022). Mobile health solutions for atrial fibrillation detection and management: a systematic review.. Clinical research in cardiology : official journal of the German Cardiac Society, 111(5), 479-491.
    DOI Scopus52 WoS24 Europe PMC41
    2022 Verhaert, D. V. M., Betz, K., Gawałko, M., Hermans, A. N. L., Pluymaekers, N. A. H. A., van der Velden, R. M. J., . . . Linz, D. (2022). A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI.. Europace, 24(4), 565-575.
    DOI Scopus29 WoS18 Europe PMC19
    2022 Wełnicki, M., Gorczyca-Głowacka, I., Lubas, A., Wójcik, W., Jelonek, O., Maciorowska, M., . . . Mamcarz, A. (2022). Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort. International Journal of Environmental Research and Public Health, 19(12), 15 pages.
    DOI Scopus4 Europe PMC3
    2022 Kapłon-Cieślicka, A., Gawałko, M., Budnik, M., Uziębło-życzkowska, B., Krzesiński, P., Starzyk, K., . . . Grabowski, M. (2022). Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry. Journal of Clinical Medicine, 11(10), 13 pages.
    DOI Scopus11 Europe PMC8
    2022 Gawałko, M., & Dobrev, D. (2022). Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation. IJC Heart and Vasculature, 39, 3 pages.
    DOI Scopus1 Europe PMC1
    2022 Budnik, M., Gawałko, M., Gorczyca, I., Uziębło-życzkowska, B., Krzesiński, P., Kochanowski, J., . . . Kapłon-Cieślicka, A. (2022). Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease. Cardiology Journal, 29(2), 205-215.
    DOI Scopus11 Europe PMC6
    2022 Pietrzak, R., Franke, M., Gawałko, M., Lodziński, P., Balsam, P., Grabowski, M., & Werner, B. (2022). Success rate and safety of catheter ablation in preexcitation syndrome: A comparison between adult and pediatric patients. Cardiology Journal, 29(1), 88-92.
    DOI Scopus3 Europe PMC3
    2021 Fender, A. C., Gawalko, M., & Dobrev, D. (2021). Direct oral anticoagulation and severe obesity – One size fits all?. IJC Heart and Vasculature, 37, 3 pages.
    DOI Scopus5 Europe PMC3
    2021 Gawałko, M., & Dobrev, D. (2021). Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited. International Journal of Cardiology, 333, 117-118.
    DOI
    2021 Lodziński, P., Gawałko, M., Kraj, L., Śliwczyński, A., Maciejewski, C., Krzowski, B., . . . Balsam, P. (2021). District versus academic hospitals: clinical outcomes of patients with atrial fibrillation. Polish Archives of Internal Medicine, 131(10), 8 pages.
    DOI Scopus5 Europe PMC2
    2021 Szpotowicz, A., Gorczyca, I., Jelonek, O., Uziębło‐życzkowska, B., Maciorowska, M., Wójcik, M., . . . Wożakowska‐kapłon, B. (2021). Why did all patients with atrial fibrillation and high risk of stroke not receive oral anticoagulants? Results of the polish atrial fibrillation (pol‐af) registry. Journal of Clinical Medicine, 10(19), 10 pages.
    DOI Scopus2 Europe PMC2
    2021 Cacko, A., Kozyra-Pydyś, E., Gawałko, M., Opolski, G., & Grabowski, M. (2021). The role of hemostatic markers as venous stenosis or occlusion predictors following first transvenous cardiac device implantation. Cardiology Journal, 28(5), 690-696.
    DOI Scopus2 Europe PMC1
    2021 Krzowski, B., Gawałko, M., Peller, M., Lodziński, P., Grabowski, M., De Potter, T., . . . Balsam, P. (2021). Radiation Safety and Electrophysiologists: Radiation Protection Status-Go for Zero Fluoroscopy European Heart Rhythm Association Registry. Cardiology (Switzerland), 146(5), 600-606.
    DOI Scopus1
    2021 Wełnicki, M., Gorczyca, I., Wójcik, W., Jelonek, O., Maciorowska, M., Uziębło-życzkowska, B., . . . Mamcarz, A. (2021). Hyperuricemia as a marker of reduced left ventricular ejection fraction in patients with atrial fibrillation: Results of the POL-AF registry study. Journal of Clinical Medicine, 10(9), 11 pages.
    DOI Scopus10 Europe PMC7
    2021 Piątkowski, R., Kucharz, J., Gawałko, M., Budnik, M., Wołosiewicz, K., Kozub, B., . . . Opolski, G. (2021). The quality of life in patients with at least moderate ischemic mitral regurgitation qualified to cardiosurgery treatment. Folia Medica Cracoviensia, 61(3), 65-83.
    DOI
    2021 Gawałko, M., & Dobrev, D. (2021). Pericardial adipose tissue: An emerging biomarker of atrial fibrillation?. International Journal of Cardiology, 331, 122-123.
    DOI
    2021 Gawałko, M., Budnik, M., Gorczyca, I., Jelonek, O., Uziębło-życzkowska, B., Maciorowska, M., . . . Kapłon-Cieślicka, A. (2021). Characteristics and treatment of atrial fibrillation with respect to the presence or absence of heart failure. Insights from the multicenter polish atrial fibrillation (POL-AF) registry. Journal of Clinical Medicine, 10(7), 17 pages.
    DOI Scopus2 Europe PMC2
    2021 Balsam, P., Lodziński, P., Gawałko, M., Kraj, L., Śliwczyński, A., Maciejewski, C., . . . Opolski, G. (2021). Antithrombotic management and long-term outcomes of patients with atrial fibrillation. Insights from craft trial. Journal of Clinical Medicine, 10(8), 12 pages.
    DOI Scopus2 Europe PMC3
    2021 Uziębło-Życzkowska, B., Krzesiński, P., Maciorowska, M., Gorczyca, I., Jelonek, O., Wójcik, M., . . . Wożakowska-Kapłon, B. (2021). Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry. Cardiovascular Diagnosis and Therapy, 11(1), 14-27.
    DOI Scopus14 Europe PMC10
    2021 Kiliszek, M., Uziębło-życzkowska, B., Gorczyca, I., Maciorowska, M., Jelonek, O., Wożakowska-Kapłon, B., . . . Krzesiński, P. (2021). Symptomatic and asymptomatic patients in the polish atrial fibrillation (Pol-af) registry. Journal of Clinical Medicine, 10(5), 1-9.
    DOI Scopus8 Europe PMC6
    2021 Gawałko, M., & Dobrev, D. (2021). Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?. IJC Heart and Vasculature, 32, 2 pages.
    DOI Scopus1 Europe PMC1
    2021 Starczyński, M., Krzowski, B., Gawałko, M., Linz, D., & Lodziński, P. (2021). Impact of photoplethysmography on therapeutic decisions in atrial fibrillation. Kardiologia Polska, 79(10), 1155-1156.
    DOI Scopus1 Europe PMC1
    2021 Hermans, A. N. L., Gawałko, M., Hillmann, H. A. K., Sohaib, A., van der Velden, R. M. J., Betz, K., . . . Linz, D. (2021). Self-Reported Mobile Health-Based Risk Factor and CHA<inf>2</inf>DS<inf>2</inf>-VASc-Score Assessment in Patients With Atrial Fibrillation: TeleCheck-AF Results. Frontiers in Cardiovascular Medicine, 8, 9 pages.
    DOI Scopus7 WoS4 Europe PMC7
    2021 Pluymaekers, N. A. H. A., Hermans, A. N. L., Van Der Velden, R. M. J., Gawałko, M., Den Uijl, D. W., Buskes, S., . . . Linz, D. (2021). Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. Europace, 23(3), 345-352.
    DOI Scopus69 WoS54 Europe PMC50
    2021 Hermans, A. N. L., Gawalko, M., Pluymaekers, N. A. H. A., Dinh, T., Weijs, B., van Mourik, M. J. W., . . . Luermans, J. G. L. M. (2021). Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation. International Journal of Cardiology, 329, 105-112.
    DOI Scopus33 WoS14 Europe PMC24
    2021 Pluymaekers, N. A. H. A., Van Der Velden, R. M. J., Hermans, A. N. L., Gawalko, M., Buskes, S., Keijenberg, J. J. H. M. W., . . . Linz, D. (2021). On-Demand Mobile Health Infrastructure for Remote Rhythm Monitoring within a Wait-and-See Strategy for Recent-Onset Atrial Fibrillation: TeleWAS-AF. Cardiology (Switzerland), 146(3), 392-396.
    DOI Scopus13 WoS8 Europe PMC10
    2021 Gawałko, M., Duncker, D., Manninger, M., Van Der Velden, R. M. J., Hermans, A. N. L., Verhaert, D. V. M., . . . Linz, D. (2021). The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: Centre and patient experiences. Europace, 23(7), 1003-1015.
    DOI Scopus78 WoS45 Europe PMC59
    2021 Gawałko, M., Linz, D., & Dobrev, D. (2021). Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?. IJC Heart and Vasculature, 34, 100818.
    DOI Scopus6 WoS3 Europe PMC4
    2021 Betz, K., van der Velden, R., Gawalko, M., Hermans, A., Pluymaekers, N., Hillmann, H. A. K., . . . Linz, D. (2021). Interpretation of photoplethysmography: a step-by-step guide. Herzschrittmachertherapie und Elektrophysiologie, 32(3), 406-411.
    DOI Scopus5 Europe PMC5
    2021 Linz, D., Gawałko, M., Sanders, P., Penders, J., Li, N., Nattel, S., & Dobrev, D. (2021). Does gut microbiota affect atrial rhythm? Causalities and speculations.. Eur Heart J, 42(35), 5 pages.
    DOI Scopus27 WoS16 Europe PMC14
    2021 Gawałko, M., Agbaedeng, T. A., Saljic, A., Müller, D. N., Wilck, N., Schnabel, R., . . . Linz, D. (2021). Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.. Cardiovasc Res, 118(11), 13 pages.
    DOI Scopus80 WoS39 Europe PMC56
    2021 Hermans, A. N. L., Gawalko, M., Dohmen, L., van der Velden, R. M. J., Betz, K., Verhaert, D. V. M., . . . Linz, D. (2021). A systematic review of mobile health opportunities for atrial fibrillation detection and management.. European journal of preventive cardiology, 29(5), E205-E208.
    DOI Scopus3 WoS2 Europe PMC1
    2021 Van Der Velden, R. M. J., Verhaert, D. V. M., Hermans, A. N. L., Duncker, D., Manninger, M., Betz, K., . . . Linz, D. (2021). The photoplethysmography dictionary: Practical guidance on signal interpretation and clinical scenarios from TeleCheck-AF. European Heart Journal - Digital Health, 2(3), 363-373.
    DOI Scopus30 WoS10 Europe PMC23
    2021 Gawałko, M., Lodziński, P., Budnik, M., Tymińska, A., Wancerz, A., Ozierański, K., . . . Balsam, P. (2021). Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry. International Journal of Clinical Practice, 75(3), 9 pages.
    DOI Scopus4 Europe PMC2
    2020 Gawałko, M., Elliott, A., Kadhim, K., Sanders, P., & Linz, D. (2020). A call for a more objective and longitudinal reporting of lifestyle components in cardiovascular research. IJC Heart and Vasculature, 27, 3 pages.
    DOI Scopus3 WoS2 Europe PMC2
    2020 Linz, B., Saljic, A., Hohl, M., Gawałko, M., Jespersen, T., Sanders, P., . . . Linz, D. (2020). Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept. IJC Heart and Vasculature, 29, 7 pages.
    DOI Scopus18 WoS8 Europe PMC8
    2020 Gawałko, M., Jespersen, T., Dobrev, D., & Linz, D. (2020). The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?. IJC Heart and Vasculature, 29, 3 pages.
    DOI Scopus1 WoS1 Europe PMC1
    2020 Hermans, A. N. L., Gawalko, M., Pluymaekers, N. A. H. A., Dinh, T., Weijs, B., Essers, B. A. B., . . . Luermans, J. G. L. M. (2020). Detection of atrial fibrillation recurrences after ablation: long-term intermittent versus short continuous heart rhythm monitoring. European Heart Journal, 41(Supplement_2), 683.
    DOI WoS1
    2020 van der Velden, R., Hermans, A., Pluymaekers, N., Gawalko, M., Vorstermans, B., Martens, H., . . . Hendriks, J. (2020). Coordination of a remote mHealth infrastructure for atrial fibrillation management during COVID-19 and beyond: TeleCheck-AF. International Journal of Care Coordination, 23(2-3), 65-70.
    DOI Scopus15 WoS11
    2020 Gawałko, M., Kapłon-Cieślicka, A., Hohl, M., Dobrev, D., & Linz, D. (2020). COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications.. International journal of cardiology. Heart & vasculature, 30, 100631.
    DOI Scopus127 WoS83 Europe PMC99
    2020 Hermans, A. N. L., van der Velden, R. M. J., Gawalko, M., Verhaert, D. V. M., Desteghe, L., Duncker, D., . . . TeleCheck-AF investigators. (2020). On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation.. Clin Cardiol, 43(11), 1232-1239.
    DOI Scopus41 WoS30 Europe PMC30
    2020 Linz, D., Mj van der Velden, R., Gawalko, M., Nl Hermans, A., Aha Pluymaekers, N., & Hendriks, J. M. (2020). Remote management and education in patients with cardiovascular conditions during COVID-19 and beyond.. Int J Cardiol Heart Vasc, 30, 100646.
    DOI Scopus3 WoS3 Europe PMC3
    2020 Gorczyca, I., Jelonek, O., Uziębło‐życzkowska, B., Chrapek, M., Maciorowska, M., Wójcik, M., . . . Wożakowska‐kapłon, B. (2020). Trends in the prescription of non‐vitamin k antagonist oral anticoagulants for atrial fibrillation: Results of the polish atrial fibrillation (pol‐af) registry. Journal of Clinical Medicine, 9(11), 1-14.
    DOI Scopus7 Europe PMC5
    2020 Gorczyca, I., Chrapek, M., Jelonek, O., Michalska, A., Kapłon-Cieślicka, A., Uziȩbło-Z yczkowska, B., . . . Woz akowska-Kapłon, B. (2020). Left Atrial Appendage Thrombus Formation despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban. Cardiology Research and Practice, 2020, 10 pages.
    DOI Scopus3 Europe PMC2
    2020 Uziębło-Życzkowska, B., Krzesiński, P., Jurek, A., Budnik, M., Gorczyca, I., Kapłon-Cieślicka, A., . . . Gielerak, G. (2020). Prevalence and risk factors of left atrial thrombus in patients with atrial fibrillation and lower class (IIa) recommendation to anticoagulants. Cardiovascular Diagnosis and Therapy, 10(4), 717-724.
    DOI Scopus5 Europe PMC6
    2020 Gawałko, M., Peller, M., Balsam, P., Grabowski, M., & Kosiuk, J. (2020). Management of cardiac arrhythmias in patients with autoimmune disease—Insights from EHRA Young Electrophysiologists. PACE - Pacing and Clinical Electrophysiology, 43(10), 1194-1198.
    DOI Scopus3 Europe PMC2
    2020 Gawałko, M., Budnik, M., Uziębło-Życzkowska, B., Krzesiński, P., Scisło, P., Kochanowski, J., . . . Kapłon-Cieślicka, A. (2020). Decreased left atrial appendage emptying velocity as a link between atrial fibrillation type, heart failure and older age and the risk of left atrial thrombus in atrial fibrillation. International Journal of Clinical Practice, 74(11), 9 pages.
    DOI Scopus12 Europe PMC9
    2020 Michalska, A., Gorczyca, I., Chrapek, M., Kapłon-Cieślicka, A., Uziȩbło-Życzkowska, B., Starzyk, K., . . . Wożakowska-Kapłon, B. (2020). Does the CHA<sup>2</sup>DS<sup>2</sup>-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?. Medicine (United States), 99(25), E20570.
    DOI Scopus4 Europe PMC3
    2020 Gorczyca, I., Michalska, A., Chrapek, M., Budnik, M., Starzyk, K., Jelonek, O., . . . Wożakowska-Kapłon, B. (2020). Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice—A multicenter registry. Journal of Cardiovascular Electrophysiology, 31(8), 2005-2012.
    DOI Scopus6 Europe PMC3
    2020 Krzowski, B., Balsam, P., Peller, M., Lodziński, P., Grabowski, M., Drozd-Sokołowska, J., . . . Kosiuk, J. (2020). Electrophysiological procedures in patients with coagulation disorders ― a systemic review ―. Circulation Journal, 84(6), 875-882.
    DOI
    2020 Uziȩbło-Życzkowska, B., Krzesiński, P., Jurek, A., Kapłon-Cieślicka, A., Gorczyca, I., Budnik, M., . . . Opolski, G. (2020). Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation. Cardiovascular Therapeutics, 2020, 7 pages.
    DOI Scopus24 Europe PMC19
    2020 Gawałko, M., Balsam, P., Lodziński, P., Grabowski, M., Krzowski, B., Opolski, G., & Kosiuk, J. (2020). Cardiac arrhythmias in autoimmune diseases. Circulation Journal, 84(5), 685-694.
    DOI Scopus67 Europe PMC52
    2020 Lodziński, P., Gawałko, M., Budnik, M., Tymińska, A., Ozierański, K., Grabowski, M., . . . Balsam, P. (2020). Trends in antithrombotic management of patients with atrial fibrillation. Polish Archives of Internal Medicine, 130(3), 196-205.
    DOI Scopus16 Europe PMC11
    2020 Grabowski, M., Marcin, M., Gawałko, M., Gajda, S., Cacko, A., Januszkiewicz, Ł., . . . Opolski, G. (2020). Implantation of the micra transcatheter pacing system: Single polish center experience with the real costs of hospitalization analysis. Cardiology Journal, 27(1), 47-53.
    DOI Scopus7 Europe PMC2
    2019 Balsam, P., Ozierański, K., Marchel, M., Gawałko, M., Niedziela, Ł., Tymińska, A., . . . Grabowski, M. (2019). Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized tornado trial. Cardiology Journal, 26(6), 661-668.
    DOI Scopus14 Europe PMC10
    2019 Kapłon-Cieślicka, A., Budnik, M., Gawałko, M., Wójcik, M., Błaszczyk, R., Uziȩbło-Zyczkowska, B., . . . Opolski, G. (2019). The rationale and design of the LATTEE registry - The first multicenter project on the Scientific Platform of the "club 30" of the Polish Cardiac Society. Kardiologia Polska, 77(11), 1078-1080.
    DOI Scopus8 Europe PMC7
    2019 Kapłon-Cieślicka, A., Piotrowska-Kownacka, D., Marchel, M., Gawałko, M., & Kochanowski, J. (2019). Left Ventricular Outflow Tract Obstruction Due to Elongation of Anterior Mitral Leaflet: A Role for Exercise Testing?. Circulation. Cardiovascular imaging, 12(11), e009524.
    DOI
    2019 Kapłon-Cieślicka, A., Budnik, M., Gawałko, M., Peller, M., Gorczyca, I., Michalska, A., . . . Opolski, G. (2019). Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart, 105(17), 1310-1315.
    DOI Scopus61 Europe PMC46
    2019 Grabowski, M., Gawałko, M., Michalak, M., Cacko, A., Kowara, M., Kołodzińska, A., . . . Opolski, G. (2019). Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center. Cardiology Journal, 26(4), 360-367.
    DOI Scopus5 Europe PMC4
    2019 Cacko, A., Kozyra-Pydyś, E., Gawałko, M., Opolski, G., & Grabowski, M. (2019). Predictors of venous stenosis or occlusion following first transvenous cardiac device implantation: Prospective observational study. Journal of Vascular Access, 20(5), 495-500.
    DOI Scopus18 Europe PMC9
    2019 Balsam, P., Gawalko, M., & Peller, M. (2019). Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study (vol 97, e13074, 2019). MEDICINE, 98(45), 1 page.
    DOI
    2019 Michalak, M., Januszkiewicz, Ł., Majstrak, F., Gawałko, M., Opolski, G., & Grabowski, M. (2019). Endovascular extraction of entrapped long-term central feeding catheter: Case series. Journal of Vascular Access, 20(3), 329-332.
    DOI Scopus1 Europe PMC1
    2019 Zbroński, K., Huczek, Z., Gawalko, M., Ćwiek, A., Rymuza, B., Grodecki, K., . . . Opolski, G. (2019). Paradoxical low-flow aortic stenosis – baseline characteristics, impact on mortality. Postepy w Kardiologii Interwencyjnej, 15(1), 13-19.
    DOI Scopus7 Europe PMC3
    2018 Balsam, P., Gawalłko, M., Peller, M., Tyminska, A., Ozieranski, K., Zaleska, M., . . . Bednarski, J. (2018). Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study. Medicine (United States), 97(45), 7 pages.
    DOI Scopus10 Europe PMC6
    2018 Cacko, A., Kondracka, A., Gawałko, M., Główczynska, R., Filipiak, K. J., Bartoszewicz, Z., . . . Grabowski, M. (2018). Novel biochemical predictors of unfavorable prognosis for stable coronary disease. Medicine (United States), 97(37), 7 pages.
    DOI Scopus4 Europe PMC3
    2018 Grabowski, M., Filipiak, K. J., Opolski, G., Główczyńska, R., Gawałko, M., Balsam, P., . . . Kochman, J. (2018). Risk factors for adverse outcomes of patients with acute coronary syndrome: Single-centre experience with long-term follow-up of treated patients. Kardiologia Polska, 76(5), 881-888.
    DOI Scopus5 Europe PMC2
    2018 Grabowski, M., Filipiak, K. J., Opolski, G., Główczyńska, R., Gawałko, M., Balsam, P., . . . Kochman, J. (2018). Long-term prognosis following acute coronary syndromes: A prospective observational study of an unselected group treated in the 24/7 cardiac catheterisation laboratory at a university hospital. Kardiologia Polska, 76(4), 755-763.
    DOI Scopus3 Europe PMC2
    2018 Pietrzak, R., Lodziński, P., Książczyk, T., Balsam, P., Gawałko, M., Opolski, G., & Werner, B. (2018). Initial experience of catheter ablation for cardiac arrhythmias in children and adolescents at a newly built ablation centre. Kardiologia Polska, 76(1), 130-135.
    DOI Scopus3 Europe PMC1
    2018 Czub, P., Cacko, A., Gawałko, M., Tataj, E., Polinski, J., Pawlik, K., . . . Hendzel, P. (2018). Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease. Medicine (United States), 97(50), 6 pages.
    DOI Scopus6 Europe PMC4
    2018 Michalik, J., Cacko, A., Poliński, J., Pawlik, K., Tataj, E., Gawałko, M., . . . Grabowski, M. (2018). An interactive assistant for patients with cardiac implantable electronic devices: A study protocol of the LUCY trial. Medicine (United States), 97(39), 4 pages.
    DOI Scopus3 Europe PMC1
    2017 Lodziński, P., Balsam, P., Peller, M., Gawałko, M., Opolski, G., & Grabowski, M. (2017). Three-dimensional print facilitated ventricular tachycardia ablation in patient with corrected congenital heart disease. Cardiology Journal, 24(5), 584-585.
    DOI Scopus4 Europe PMC4
    2017 Grabowski, M., Gawałko, M., Michalak, M., Cacko, A., & Opolski, G. (2017). Ventricular tachycardia successfully treated with wearable cardioverter-defibrillator. Kardiologia Polska, 75(12), 1355.
    DOI
    2017 Gawałko, M., KapłonCieślicka, A., Budnik, M., Babiarz, A., Bodys, A., Uliński, R., . . . Opolski, G. (2017). Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion. Polish Archives of Internal Medicine, 127(12), 823-831.
    DOI Scopus19 Europe PMC11
    2017 Gawalko, M., Kołodzińska, A., Grabowski, M., Kutarski, A., & Opolski, G. (2017). Transvenous lead removal with a fragment of a papillary muscle - a silent complication.. Heart Beat Journal, 1, 41-42.
    DOI
    2017 Balsam, P., Gawalko, M., Lodziński, P., Grabowski, M., Kołtowski, Ł., Peller, M., & Opolski, G. (2017). Atrioventricular block registration with smart phone associated ECG device.. Heart Beat Journal, 1, 54-55.
    DOI
    - Szpotowicz, A., Gorczyca-Głowacka, I., Uziębło-Życzkowska, B., Maciorowska, M., Wójcik, M., Błaszczyk, R., . . . Wożakowska-Kapłon, B. (n.d.). Czy wynik CHA2DS2-VASc determinuje leczenie przeciwzakrzepowe u pacjentów z migotaniem przedsionków? Dane z POLish Atrial Fibrillation (POL-AF) Registry?. Folia Cardiologica, 16(6), 359-368.
    DOI
    - Bednarski, J., Bakuła-Ostalska, E., Gorczyca, I., Jelonek, O., Wożakowska-Kapłon, B., Uziębło-Życzkowska, B., . . . Mamcarz, A. (n.d.). Clinical characteristics of patients based on the POL-AF registry compared to the registries of the pre - NOACs era. Do we still treat the same individuals?. Vascular Diseases and Therapeutics, 6(2).
    DOI

  • Conference Papers
    Year Citation
    2022 Wybraniec, M., Mizia-Szubryt, M., Gawalko, M., Uzieblo-Zyczkowska, B., Gorczyca-Glowacka, I., Kaufmann, D., . . . Mizia-Stec, K. (2022). Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry. In EUROPEAN HEART JOURNAL Vol. 43 (pp. 622). OXFORD UNIV PRESS.
    2021 Hermans, A. N. L., Gawalko, M., Van der Velden, R. M. J., Verhaert, D. V. M., Betz, K., Hemels, M. E. W., . . . Linz, D. (2021). Evaluation of the feasibility and accuracy of remote mobile app-based self-reported atrial fibrillation risk factor assessment in patients with atrial fibrillation: TeleCheck-AF results. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 3095). OXFORD UNIV PRESS.
    2021 Van der Velden, R. M. J., Verhaert, D. V. M., Hermans, A. N. L., Gawalko, M., Duncker, D., Manninger, M., . . . Linz, D. (2021). The photoplethysmography dictionary: practical guidance on signal interpretation and clinical scenarios from TeleCheck-AF. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 320). ELECTR NETWORK: OXFORD UNIV PRESS.
    WoS8

SELECTED RESEARCH PROJECTS 

  • First-time Ablation of Atrial Fibrillation Registry (DIPE; NCT06381245); Principal Investigator
  • Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units (POL-CICU; NCT06371677); Principal Investigator
  • Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE; NCT03591627); Sub-Investigator and data management coordinator
  • Nationwide registry of patients with atrial fibrillation (POL-AF; NCT04419012); Sub-Investigator
  • MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT; NCT02987062); Sub-Investigator
  • Paracrine effect of pericardial adipose tissue on atrial fibrillation (PAT-AF) within MAESTRIA consortium (Machine Learning and Artificial Intelligence for Early Detection of Stroke and AF); Sub-Investigator
  • On-demand app-based management of atrial fibrillation (TeleCheck-AF); Sub-Investigator
  • A VIRTUAL Sleep Apnea management pathway For the workup of Atrial fibrillation patients in a digital Remote Infrastructure (VIRTUAL-SAFARI); Sub-Investigator
  • Atriumfalen: De link tussen atriumfibrilleren en hartfalen (Möller Fonds); Sub-Investigator

Research-Training Assistant at Department of Cardiology, Medical University of Warsaw (Poland) from 2019

  • Other Supervision Activities
    Date Role Research Topic Location Program Supervision Type Student Load Student Name
    2024 - ongoing Principal Supervisor Cardiac remodelling in patients with atrial fibrillation undergoing catheter ablation Medical University of Warsaw - Doctorate - K.Rutkowski
    2024 - ongoing Principal Supervisor Role of cardiac autonomic nervous system in patients with atrial fibrillation undergoing catheter ablation Medical University of Warsaw - Doctorate - J.Szydlik
    2023 - ongoing Co-Supervisor The atrial fibrillation burden during the blanking period and its predictive value for late recurrence after catheter ablation Medical University of Warsaw - Doctorate - M.Gawlik

  • Mentoring
    Date Topic Location Name
    2023 - ongoing Multimodal imaging in atrial fibrillation and heart failure with preserved ejection fraction Medical University of Warsaw A.Skrobucha
    2023 - ongoing Fatty liver disease and atrial fibrillation Medical University of Warsaw M.Boszko

  • Committee Memberships
    Date Role Committee Institution Country
    2024 - ongoing Board Member European Society of Cardiology Working Group on e-Cardiology, Community Coordinator and Nucleus Member European Society of Cardiology France
    2022 - 2024 Member European Association of Preventive Care (EAPC), Young Ambassador European Society of Cardiology France
    2022 - 2024 Member European Association of Preventive Care (EAPC), Social Media Ambassador European Society of Cardiology France
    2022 - ongoing Member European Society of Cardiology Social Media Editorial Team European Society of Cardiology France

  • Memberships
    Date Role Membership Country
    2024 - ongoing Member Fellow of the European Heart Rhythm Association France
    2023 - 2024 Member Council of Young Scientists, Medical University of Warsaw Poland
    2022 - ongoing Member Club 30 Polish Cardiac Society Poland
    2021 - ongoing Member Polish Cardiac Society, Heart Rhythm Association Poland
    2020 - 2022 Member European Heart Journal, Mentorship programme France

  • Presentation
    Date Topic Presented at Institution Country
    2025 - ongoing Cardiac arrhythmias: atrial fibrillation - CBCS Summer School France
    2025 - ongoing Biomarkers of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation. Insights from RACE 7 ACWAS trial - Heart Rhythm Association Congress United States
    2025 - ongoing Influence of renal function and dose of non-vitamin K antagonist oral anticoagulants on left atrial thrombus risk in patients with atrial fibrillation. Insights from LATTEE registry - Heart Rhythm Association Congress United States
    2025 - ongoing Left atrial strain is associated with atrial fibrillation recurrence after catheter ablation. Data from the ISOLATION registry. - European Heart Rhythm Association Congress Austria
    2025 - ongoing Discordance between different diagnostic criteria to assess probability of heart failure with preserved ejection fraction in patients with atrial fibrillation referred for catheter ablation - European Heart Rhythm Association Congress Austria
    2024 - ongoing What is the natural history of atrial fibrillation progression? - Asia-Pacific Heart Rhythm Society Conference Australia
    2024 - ongoing Adipose tissue as novel driver of cardiac arrhythmogenesis - Frontiers in CardioVascular Biomedicine Conference Netherlands
    2024 - ongoing Identification of heart failure with preserved ejection fraction and its high probability in patients with atrial fibrillation referred for catheter ablation - European Heart Rhythm Association Congress Germany
    2024 - ongoing Patient with atrial flutter – what is the risk that he also has fibrillation and how to treat with anticoagulation? - Arythmix Conference Poland
    2024 - ongoing Atrial fibrillation and air pollution, but also lung diseases - Arythmix Conference Poland
    2023 - ongoing Gut Microbiome in Cardiovascular Health ECR - Proteinech. Gut Microbiome in Cardiovascular Health ECR Event United States
    2023 - ongoing Clinical implications of inflammasome signaling in atrial fibrillation - European Heart Rhythm Association Congress Spain
    2023 - ongoing Left atrial strain is associated with atrial fibrillation recurrence after catheter ablation: Data from the ISOLATION registry - European Heart Rhythm Association Congress Spain
    2023 - ongoing Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients - European Heart Rhythm Association Congress Spain
    2022 - ongoing How to design a study that informs guidelines and clinical practice? - European Heart Rhythm Association Summit Croatia
    2022 - ongoing Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose induced activation of NLRP3 inflammasome - Webinar for IHU Liryc – L’institut de Rythmologioe et de modelisation Cardiaque Electriohysiology and Heart Modeling Instutute France
    2022 - ongoing Gut microbiota: dysbiosis and atrial fibrillation - Frontiers in CardioVascular Biomedicine Congress Hungary
    2022 - ongoing Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry - European Heart Rhythm Association Congress Denmark
    2022 - ongoing Patient motivation and adherence to an on-demand app-based heart rate and rhythm monitoring infrastructure for atrial fibrillation management through teleconsultation. TeleCheck-AF project results - European Heart Rhythm Association Congress Denmark
    2020 - ongoing The relevance of computed tomography and magnetic resonance imaging prior to pulmonary vein isolation on fluoroscopy exposure and procedure time - European Heart Rhythm Association Congress -
    2020 - ongoing Older age, heart failure and renal dysfunction are associated with decreased left atrial appendage emptying velocity in atrial fibrillation - European Heart Rhythm Association Congress -
    2020 - ongoing Risk of left atrial appendage thrombus in elderly patients with atrial fibrillation - Acute Cardiovascular Care Congress Greece
    2019 - ongoing Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus in atrial fibrillation - proposal of a new score - European Heart Rhythm Association Congress Portugal
    2019 - ongoing Risk of left atrial appendage thrombus in elderly patients with atrial fibrillation - XXIII International Congress of the Polish Scientific Society Poland
    2018 - ongoing Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus in atrial fibrillation - proposal of a new score - Scientific Conference of the Prevention and Epidemiology Section of the Polish Cardiac Society, „Preventive Cardiology 2018” Poland
    2018 - ongoing Risk of left atrial thrombus in patients with atrial fibrillation - XXIX Conference of the Heart Rhythm Section of the Polish Cardiac Society. POLSTIM Poland
    2017 - ongoing Comparison of different anticoagulant therapies in patients with atrial fibrillation undergoing ablation or cardioversion - XXVIII Conference of the Heart Rhythm Section of the Polish Cardiac Society. POLSTIM Poland
Connect With Me
External Profiles